Real-World data registry aims to map best treatment paths for advanced colorectal cancer

NCT ID NCT04867525

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This registry tracks adults with metastatic colorectal cancer who are starting their first systemic therapy. Researchers will collect information on the treatments doctors choose, how well they work, and patients' quality of life. The goal is to understand what happens in everyday medical practice, beyond controlled clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this registry could reveal which treatment sequences work best in everyday practice, helping doctors make more informed decisions for patients with metastatic colorectal cancer.
What could go wrong
As an observational registry, it does not test a new treatment, so it cannot prove cause and effect. Results may be influenced by patient selection and real-world variability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Multiple sites all over germany

    Multiple Locations, Germany, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.